Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02828475 · ClinicalTrials.gov registry record
CALYPSO Pilot Study: Machine Learning Based Predictions of Surgical Complications
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 200
- Enrollment target
NCT02828475: Completed study, sponsored by Duke University.
NCT02828475 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02828475 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
This is a pilot study of surgical patients whose postoperative care will be augmented with a personalized risk prediction platform (CALYPSO app).
Interventions
- BEHAVIORAL Standard Care
- OTHER CALYPSO
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2016-06 |
| Est. Completion | 2017-02 |
What the finished NCT02828475 record still lists
NCT02828475 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Standard Care is the first listed.
NCT02828475 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02828475 about?
NCT02828475 is a clinical study titled "CALYPSO Pilot Study: Machine Learning Based Predictions of Surgical Complications". This is a pilot study of surgical patients whose postoperative care will be augmented with a personalized risk prediction platform (CALYPSO app).
What is the current status of trial NCT02828475?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2016-06. Estimated completion is 2017-02.
What interventions are being tested in trial NCT02828475?
The interventions under investigation include: Standard Care (BEHAVIORAL), CALYPSO (OTHER).
Who is sponsoring clinical trial NCT02828475?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia